Artal Group as of June 30, 2020
Portfolio Holdings for Artal Group
Artal Group holds 127 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ww Intl (WW) | 10.5 | $376M | 15M | 25.38 | |
| JPMorgan Chase & Co. Call Option (JPM) | 7.9 | $282M | 3.0M | 94.06 | |
| Beigene Sponsored Adr (BGNE) | 4.5 | $160M | 850k | 188.40 | |
| Alnylam Pharmaceuticals (ALNY) | 4.1 | $148M | 1.0M | 148.11 | |
| Biontech Se Sponsored Ads (BNTX) | 4.0 | $144M | 2.2M | 66.74 | |
| Acceleron Pharma | 3.7 | $133M | 1.4M | 95.27 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 3.4 | $120M | 60M | 2.00 | |
| Argenx Se Sponsored Adr (ARGX) | 2.8 | $101M | 450k | 225.23 | |
| GDS HLDGS Sponsored Ads (GDS) | 2.5 | $88M | 1.1M | 79.66 | |
| Schrodinger (SDGR) | 2.3 | $82M | 897k | 91.57 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.2 | $80M | 373k | 215.70 | |
| Amicus Therapeutics (FOLD) | 1.9 | $68M | 4.5M | 15.08 | |
| Black Diamond Therapeutics (BDTX) | 1.8 | $65M | 1.5M | 42.16 | |
| Fate Therapeutics (FATE) | 1.7 | $62M | 1.8M | 34.31 | |
| Generation Bio (GBIO) | 1.7 | $59M | 2.8M | 21.00 | |
| Alexion Pharmaceuticals Call Option | 1.6 | $56M | 500k | 112.24 | |
| Citigroup Com New Call Option (C) | 1.4 | $51M | 1.0M | 51.10 | |
| Epizyme | 1.3 | $46M | 2.9M | 16.06 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $46M | 2.5M | 18.21 | |
| Morphic Hldg (MORF) | 1.3 | $45M | 1.7M | 27.05 | |
| Uniqure Nv SHS (QURE) | 1.3 | $45M | 1.0M | 45.06 | |
| Blueprint Medicines (BPMC) | 1.2 | $43M | 550k | 78.00 | |
| Goldman Sachs Call Option (GS) | 1.1 | $40M | 200k | 197.62 | |
| Deciphera Pharmaceuticals (DCPH) | 1.1 | $39M | 650k | 59.72 | |
| Atara Biotherapeutics (ATRA) | 1.0 | $36M | 2.5M | 14.57 | |
| Royalty Pharma Shs Cl A (RPRX) | 1.0 | $36M | 750k | 48.55 | |
| Delta Air Lines Inc Del Com New Call Option (DAL) | 1.0 | $35M | 1.3M | 28.05 | |
| Paypal Holdings (PYPL) | 1.0 | $35M | 200k | 174.23 | |
| Gossamer Bio (GOSS) | 1.0 | $35M | 2.7M | 13.00 | |
| Tg Therapeutics (TGTX) | 1.0 | $34M | 1.8M | 19.48 | |
| Avantor (AVTR) | 1.0 | $34M | 2.0M | 17.00 | |
| Moderna (MRNA) | 0.9 | $32M | 500k | 64.21 | |
| Select Sector Spdr Tr Sbi Int-inds Call Option (XLI) | 0.9 | $31M | 450k | 68.70 | |
| Translate Bio | 0.8 | $29M | 1.6M | 17.92 | |
| Zillow Group Cl C Cap Stk (Z) | 0.8 | $28M | 483k | 57.61 | |
| American Airls (AAL) | 0.7 | $26M | 2.0M | 13.07 | |
| Abbvie Call Option (ABBV) | 0.7 | $25M | 250k | 98.18 | |
| Novagold Res Com New (NG) | 0.7 | $24M | 2.6M | 9.18 | |
| Bank of America Corporation Call Option (BAC) | 0.7 | $24M | 1.0M | 23.75 | |
| Rubius Therapeutics | 0.6 | $23M | 3.9M | 5.98 | |
| Turning Point Therapeutics I | 0.6 | $23M | 350k | 64.59 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $20M | 376k | 53.48 | |
| Bridgebio Pharma (BBIO) | 0.5 | $20M | 600k | 32.61 | |
| Adverum Biotechnologies | 0.5 | $19M | 900k | 20.88 | |
| Mersana Therapeutics (MRSN) | 0.5 | $19M | 800k | 23.40 | |
| Replimune Group (REPL) | 0.5 | $19M | 750k | 24.85 | |
| Repare Therapeutics Ord (RPTX) | 0.5 | $19M | 600k | 31.02 | |
| Bio-techne Corporation (TECH) | 0.5 | $17M | 65k | 264.08 | |
| Fibrogen (FGEN) | 0.5 | $16M | 400k | 40.53 | |
| Aravive | 0.4 | $16M | 1.4M | 11.64 | |
| Trip Com Group Ads (TCOM) | 0.4 | $16M | 600k | 25.92 | |
| Harpoon Therapeutics | 0.4 | $15M | 900k | 16.60 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $15M | 900k | 16.25 | |
| 21vianet Group Sponsored Ads (VNET) | 0.4 | $14M | 583k | 23.86 | |
| Iovance Biotherapeutics (IOVA) | 0.4 | $14M | 500k | 27.45 | |
| Albireo Pharma | 0.4 | $13M | 500k | 26.49 | |
| Y Mabs Therapeutics (YMAB) | 0.4 | $13M | 300k | 43.20 | |
| General Motors Company Call Option (GM) | 0.4 | $13M | 500k | 25.30 | |
| Springworks Therapeutics (SWTX) | 0.4 | $13M | 300k | 42.00 | |
| Principia Biopharma | 0.3 | $12M | 200k | 59.79 | |
| Stoneco Com Cl A (STNE) | 0.3 | $11M | 290k | 38.76 | |
| Agenus Com New (AGEN) | 0.3 | $11M | 2.9M | 3.93 | |
| Denali Therapeutics (DNLI) | 0.3 | $11M | 450k | 24.18 | |
| Cyclerion Therapeutics | 0.3 | $11M | 1.8M | 5.88 | |
| Aeglea Biotherapeutics | 0.3 | $10M | 1.1M | 9.25 | |
| Sage Therapeutics (SAGE) | 0.3 | $9.7M | 234k | 41.58 | |
| I Mab Sponsored Ads (IMAB) | 0.3 | $9.7M | 324k | 29.93 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.3 | $9.6M | 65k | 147.91 | |
| Kura Oncology (KURA) | 0.3 | $9.4M | 578k | 16.30 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $9.1M | 188k | 48.38 | |
| Accelr8 Technology | 0.2 | $8.9M | 587k | 15.16 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $8.6M | 234k | 36.83 | |
| Krystal Biotech (KRYS) | 0.2 | $8.3M | 200k | 41.42 | |
| Selecta Biosciences (RNAC) | 0.2 | $8.2M | 2.9M | 2.84 | |
| Immunomedics | 0.2 | $8.2M | 231k | 35.44 | |
| Tricida | 0.2 | $7.8M | 285k | 27.48 | |
| Akebia Therapeutics (AKBA) | 0.2 | $7.8M | 574k | 13.58 | |
| Melco Resorts And Entmnt Adr Call Option (MLCO) | 0.2 | $7.8M | 500k | 15.52 | |
| Trillium Therapeutics Com New | 0.2 | $7.7M | 953k | 8.09 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.2 | $7.7M | 1.3M | 6.08 | |
| Bruker Corporation (BRKR) | 0.2 | $7.5M | 185k | 40.68 | |
| Spero Therapeutics (SPRO) | 0.2 | $7.4M | 545k | 13.53 | |
| Immunic (IMUX) | 0.2 | $7.3M | 600k | 12.12 | |
| Hookipa Pharma Inc equity (HOOK) | 0.2 | $7.0M | 600k | 11.62 | |
| Stoke Therapeutics (STOK) | 0.2 | $6.8M | 285k | 23.83 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $6.6M | 985k | 6.73 | |
| Aptinyx | 0.2 | $6.6M | 1.6M | 4.17 | |
| Autolus Therapeutics Sponsored Ads (AUTL) | 0.2 | $6.4M | 400k | 16.03 | |
| Passage Bio (PASG) | 0.2 | $6.4M | 234k | 27.33 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $6.4M | 136k | 46.81 | |
| Leap Therapeutics | 0.2 | $6.2M | 3.0M | 2.09 | |
| Merus N V (MRUS) | 0.2 | $6.2M | 384k | 16.09 | |
| Huazhu Group Sponsored Ads (HTHT) | 0.2 | $6.1M | 175k | 35.05 | |
| Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM) | 0.2 | $5.7M | 100k | 56.77 | |
| Nektar Therapeutics (NKTR) | 0.2 | $5.5M | 239k | 23.16 | |
| Prevail Therapeutics Ord | 0.2 | $5.5M | 370k | 14.90 | |
| Tcr2 Therapeutics Inc cs | 0.2 | $5.4M | 350k | 15.36 | |
| Solid Biosciences | 0.1 | $5.3M | 1.8M | 2.93 | |
| Syros Pharmaceuticals | 0.1 | $5.2M | 490k | 10.66 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $5.1M | 150k | 33.73 | |
| Intellia Therapeutics (NTLA) | 0.1 | $5.0M | 239k | 21.02 | |
| Axcella Health Inc equity | 0.1 | $5.0M | 900k | 5.53 | |
| Avidity Biosciences Ord (RNA) | 0.1 | $4.9M | 175k | 28.26 | |
| Alector (ALEC) | 0.1 | $4.9M | 200k | 24.44 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $4.4M | 92k | 48.02 | |
| 111 Ads (YI) | 0.1 | $4.1M | 650k | 6.35 | |
| Prothena Corp SHS (PRTA) | 0.1 | $3.9M | 370k | 10.46 | |
| Kaleido Biosciences Ord (KLDO) | 0.1 | $3.7M | 501k | 7.43 | |
| Ideaya Biosciences (IDYA) | 0.1 | $3.4M | 239k | 14.21 | |
| Magenta Therapeutics | 0.1 | $3.4M | 450k | 7.51 | |
| Clovis Oncology Call Option | 0.1 | $3.4M | 500k | 6.75 | |
| Evelo Biosciences | 0.1 | $3.3M | 667k | 4.90 | |
| Mei Pharma Com New | 0.1 | $2.9M | 714k | 4.13 | |
| Minerva Neurosciences | 0.1 | $2.9M | 800k | 3.61 | |
| Cryoport Com Par $0.001 (CYRX) | 0.1 | $2.7M | 89k | 30.25 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $2.5M | 140k | 17.66 | |
| Orchard Therapeutics Ads | 0.1 | $2.2M | 370k | 6.00 | |
| Aduro Biotech | 0.1 | $2.2M | 950k | 2.31 | |
| Restorbio | 0.1 | $2.0M | 953k | 2.15 | |
| Select Sector Spdr Tr Energy Call Option (XLE) | 0.1 | $1.9M | 50k | 37.86 | |
| Curis Com New | 0.1 | $1.8M | 1.5M | 1.21 | |
| Vaxart Com New (VXRT) | 0.0 | $1.8M | 200k | 8.85 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $1.6M | 188k | 8.33 | |
| Bellus Health Com New | 0.0 | $1.5M | 144k | 10.29 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.1M | 111k | 10.32 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $873k | 237k | 3.69 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $619k | 338k | 1.83 |
